In a significant move toward advancing pharmaceutical packaging innovation and sustainability, Honeywell (NASDAQ: HON) has announced that Evertis, a prominent film producer, has selected its medical-grade Aclar® film for use in the Evercare brand’s pharmaceutical applications. This collaboration aims to ensure safer, longer-lasting medication packaging while promoting recyclable solutions within the pharmaceutical industry.
Honeywell’s Aclar® film is renowned for offering the highest moisture barrier available among polymer films, making it essential for preserving the efficacy and stability of both prescription and OTC medications. By extending shelf life and minimizing waste, Aclar positions itself as a critical material in healthcare packaging one that aligns with growing regulatory and sustainability demands.
Evertis will integrate Aclar into medical-grade polyethylene terephthalate (PET) structures, widely used across industries for their lightweight, durable, and cost-efficient properties. Aclar enhances these PET-based films with superior barrier protection, thermoforming precision, and clarity all crucial for pharmaceutical use.
Casimiro Sacchetti, CSO of Evertis Americas, shared his enthusiasm:
“Partnering with Honeywell allows us to offer the pharmaceutical industry PET-based films with exceptional performance. Combining our lamination and film expertise with Aclar’s barrier technology delivers packaging solutions that meet stringent pharmaceutical requirements while also addressing recyclability and cost efficiency.”
Aclar film also stands out for its recyclability through specialized production techniques that allow easy separation, helping packaging manufacturers respond to the growing demand for circular economy practices.
Jeff Dormo, President of Sustainability and Decarbonization at Honeywell, emphasized the broader mission:
“Aclar has supported pharmaceutical safety for over 50 years. By collaborating with Evertis, we’re continuing that legacy while addressing modern needs empowering safer, more sustainable drug delivery systems that protect both patient health and the environment.”
The resulting PET-based packaging solutions are slated for market release in 2025, signaling a pivotal shift in sustainable pharmaceutical design. This also comes ahead of Honeywell’s anticipated spin-off of its Advanced Materials division, which will rebrand as Solstice Advanced Materials by early 2026, continuing to lead innovations across chemicals, refrigerants, and healthcare packaging.